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1. Introduction 
Since its discovery in the PC12 rat pheochromocytoma cell line (Montminy & Bilezikjian 
1987) the cAMP Response Element Binding (CREB) protein has been implicated in a variety 
of neuronal responses such as excitation, long-term memory formation, neural cell 
proliferation and opiate tolerance. Its importance is underscored by the attention this factor 
has attracted in the neuroscience community, as evidenced by the thousands of citations in 
the academic bibliographic databases. CREB is a transcription factor which potentially 
regulates the transcription of hundreds or even thousands of genes in neurons. A variety of 
protein kinases possess the capability of driving CREB phosphorylation and activation, 
placing CREB at a hub of multiple intraneuronal signalling cascades. The array of neuronal 
functions attributed to CREB has expanded recently, with studies showing that CREB has 
role in neural stem/progenitor cell growth, differentiation and survival. This data, together 
with complementary studies in tissues outside the CNS showing that CREB activation has 
oncogenic effects has led to the hypothesis that CREB has an important role in brain tumour 
biology. Therefore, CREB is a factor which sits within a molecular network potentially 
integrating signalling events regulating neural stem cells and neurogenesis, neural cancer 
cells and other cells within brain tumors. 
To gain an the understanding of the link between stem cells normally residing in the adult 
brain and the stem cells which can give rise to a brain tumour, it is important to introduce 
the concepts relating to the so-called ‘cancer stem cell hypothesis’. Indeed, one of the most 
important advances in brain tumour biology has been the discovery that tumors can 
develop from cells with stem cell-like characteristics. The reason for the excitement is better 
understood when one considers the nature of treatments of typical cancers/tumors in a 
patient. The most relevant example to consider in the context of this chapter is the most 
common and deadly brain tumour, glioblastoma multiforme (high-grade glioma). Gliomas 
are difficult to treat and patients usually succumb within months to 1-2 years, even with 
multiple treatment approaches. Standard treatments rely on ‘debulking’ of the tumour(s), 
achieved by surgical excision and/or cytotoxic therapies, usually radiation and 
chemotherapy. Almost inevitably, this first treatment is followed by relatively rapid relapse 
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and aggressive tumour recurrence. Considering the existence of glioma cancer stem cells, 
which give rise to the original tumour mass, it has become clear that these cells, which 
although few in number, probably lie at the periphery or even outside the main tumour 
mass and are also resistant to current cytotoxic therapies. Thus, surgery only removes the 
large tumour mass and cancer stem cells within, sparing other cancer stem cells outside the 
main tumour mass. These surviving cancer stem cells are able to give rise to the 
recurring/secondary tumors, which have also evolved to become more resistant to further 
treatments. Thus, much research has focussed on stem cell biology in the context of cancer 
and the processes which give rise to cancer stem cells or tumour initiating cells. Research on 
the mechanisms that play a role in neural birth and brain development are gaining traction 
in the understanding of brain tumour biology, since there must be common molecular 
genetic mechanisms operating in both normal/non-tumor neural stem cells and neural 
cancer stem cells. Indeed, once the parallel mechanisms are understood, then the differences 
will also become apparent. These differences will also provide the rational basis for 
therapeutic targeting of neural cancer stem cells. 
Aside from contributing to furthering the understanding of the ongoing cellular plasticity of 
the brain, the knowledge that adult organs, including the brain, harbour stem and 
progenitor cells throughout the life of the organism has helped develop new concepts on 
what happens when these cells accumulate mutations in the context of diseases such as 
cancer. Indeed, the understanding of cancer stem cells has provided a new optimism in the 
development of novel strategies for cancer therapy (Schatton et al. 2009). The signalling 
networks operating in normal neural and brain tumour initiating cells involve complex 
molecular networks. At the hub of these networks are the transcription factors, which 
determine which genes are expressed, when they are expressed and how much of each 
corresponding mRNA is expressed. There are many transcription factors which have been 
identified as being important for neural stem cell function but research linking transcription 
factors regulating normal stem cells and cancer stem cells is still at an early stage. In fact, 
little is known about what distinguishes a cancer stem cell from a physiologically normal 
stem cell. 
2. Neural stem cells and neurogenesis 
The origins of the mammalian central nervous system lie within the neuroepithelium, a thin 
layer of developing nerve cells. Much of this early developmental period in vertebrates is 
dedicated to organising the structure of the brain. This organisation precedes a period of 
rapid cellular expansion, the peak of neurogenesis. 
The discovery that neurogenesis persists in the adult vertebrate brain was contrary to the 
long-held dogma, oft quoted as Santiago Ramon y Cajal’s statement referring to the central 
nervous system that “...nothing may be regenerated”. Of course, the available methods over 
a century ago made it almost impossible to observe or measure the minute fraction of nerve 
cells undergoing cell division amongst the billions of postmitotic cells in an adult 
mammalian brain. Since Cajal’s time there were sporadic but important reports on the 
existence of mitotic cells in mature adult mammalian brains (Allen 1912; Altman & Das 
1965). The prevailing understanding of neurogenesis is that neural stem cells arise during 
embryogenesis, and a fraction of these persist into adulthood within discrete regions of 
adult brain (“neurogenic regions”) (reviewed in (Abrous et al. 2005)). These cells are distinct 
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from other, non-neural cell types in the brain (most notably microglia – the “immune cells” 
of the brain) which retain the ability to proliferate, but cannot generate cells of other neural 
lineages. Cells fulfilling the criteria of “stemness” (self-renewal, multipotentiality) have been 
identified in the brains of higher vertebrates, including humans (Eriksson et al. 1998). The 
best characterised neurogenic regions in higher vertebrates lie in the sub-ventricular zone of 
the lateral ventricles and the sub-granular zone of the hippocampus. The number of 
proliferating cells and newborn neurons in the dentate gyrus, olfactory bulb and sub-
ventricular zone decreases with age (Altman & Das 1965; Kuhn et al. 1996), consistent with 
an age-dependent decline in neurogenic potential. As mentioned previously, there are many 
factors which regulate neurogenesis, including transcription factors. The CREB transcription 
factor has only recently been recognised to play an important role in this process. This factor 
is at the hub of multiple signalling cascades, which are active in neural stem cells and 
regulates the expression of a series of downstream target genes important for stem cell 
survival and growth (see Figure 1). 
 
Fig. 1. Several pathways lead to CREB phosphorylation/activation to promote cell survival, 
proliferation and differentiation. In the context of neural stem cells and cancer, Receptor 
Tyrosine Kinases (RTKs) are important, since their ligands such as EGF and PDGF are 
growth factors necessary for cell survival and proliferation. However, the role of the other 
pathways shown, remain to be investigated in this context. Note that dephosphorylation of 
CREB via phosphatases occurs via the activity of PTEN and PP1. PTEN may be critical in the 
context of brain tumors and CREB signalling, as it is often mutated in gliomas. 
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In the context of neural stem cells and cancer, Receptor Tyrosine Kinases (RTKs) are 
important, since the ligands for these receptors such as EGF and PDGF are growth factors 
and necessary for cell survival and proliferation. However, the roles of the other pathways 
shown remain to be investigated in this context. Note that dephosphorylation of CREB via 
phosphatases occurs via the activity of PTEN and PP1. PTEN may be critical in the context 
of brain tumors and CREB signalling, as it is often mutated in glioma. 
3. The CREB transcription factor family 
Transcription factors are the terminal convergence points of many signalling pathways, 
these genes function as effector molecules to activate downstream target genes which in 
turn regulate NSPC proliferation, cell-cycle exit, induction of differentiation and survival 
(for a concise review see (Ahmed et al. 2009)). The precise cell stage at which a particular 
transcription factor is active determines its contribution to the cell’s progression from 
immaturity to maturity. 
CREB is a nuclear-localised basic leucine zipper superfamily transcription factor, acting as a 
conduit between upstream signalling kinases and downstream target-gene transcription. 
Three major isoforms of CREB are known (ǂ, Δ and Ǆ), all transcribed from the same gene, 
CREB1. Although the best characterised member of the CREB family is CREB itself 
(Montminy & Bilezikjian 1987), the family also includes CREM (Foulkes et al. 1991) and 
ATF1 (Hai et al. 1988), products of distinct genes. These transcription factors are able to 
homodimerize or heterodimerize with each other, bind to cyclic-AMP Response Element 
(CREs) sequences present in target gene promoters and are activated by serine-threonine 
kinases targeting the phosphorylation of their Kinase-Inducible Domain (KID). Thus, there 
is an inherent functional redundancy in the CREB transcription factor family which has been 
shown in mouse knockout studies, where CREB deletion results in an upregulation of 
CREM expression in an attempt to compensate for many of the cellular functions normally 
attributed to CREB (Blendy et al. 1996; Mantamadiotis et al. 2002). Phosphorylation of the 
KID then causes increased affinity to various transcriptional coactivators such as CREB-
Binding Protein (CBP), p300 and the Transducers Of Regulated CREB activity (TORCs), 
which then leads to the assembly of the transcriptional machinery and transcription 
initiation. The CREB transcription factor family are potent transcriptional activators 
although there is some evidence that in certain contexts these factors are capable of 
repressing transcription (Rutberg et al. 1999). 
3.1 CREB in NSPCs and neurogenesis 
CREB’s role in embryonic brain development and neurogenesis is conserved across at least 
two vertebrate species separated by over 300 million years of evolution, as studies in zebrafish 
embryos show that CREB has a role in developmental neurogenesis and in midbrain-
hindbrain patterning (Dworkin et al. 2007). There is also evidence that CREB has a role in the 
regeneration of the simple nerve net in Hydra species and the more complex nervous system of 
the roundworm Caenorhabditis elegans (Chera et al. 2007; Ghosh-Roy et al. 2010). 
In the developing mouse brain, the active phosphorylated form of CREB is seen in cells 
clustered in the neurogenic regions at E14.5, a time when the brain takes on recognisable 
neuro-anatomical features and neurogenesis peaks and becomes regionally localised. These 
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regions include the ventricular zones of both the lateral and third ventricles and the 
olfactory bulb (Dworkin et al. 2009). Consistent with a role in neurogenesis, the activated, 
phosphorylated form of CREB, pCREB is enriched and restricted to the neurogenic zones of 
the adult mouse brain, whereas total (unphosphorylated and phosphorylated) CREB protein 
is present in almost all cells of the brain (Figure 2). 
 
Fig. 2. Immunohistochemical analysis of CREB protein expression in mouse brain. 
A) A coronal section of mouse brain showing the global expression of CREB protein 
(phosphorylated and unphosphorylated). The positive signals are evident as the dark 
nuclear staining in each cell/neuron. The neurogenic zones, SGZ (sub-granular zone) of the 
dentate gyrus (DG) located in the hippocampus and SVZ (sub-ventricular zone) are 
indicated by the dark lines and labels (x4 power). B) In contrast to total CREB protein 
expression, phospho-CREB expression is evident and restricted to the neurogenic sub-
granular zone (SGZ) of the hippocampal dentate gyrus (DG), where some positive cells are 
indicated by the arrow heads. C) phospho-CREB expression is evident in the SVZ, where 
some positive cells are indicated by the arrow heads. (B & C x100). 
Regulated transient CREB phosphorylation and de-phosphorylation is a well described 
mechanism by which neuronal activity is regulated in many regions of adult mouse brain 
(Lonze & Ginty 2002). Moreover, CREB is required for the survival of post-mitotic neurons 
in mouse brain (Ao et al. 2006; Dworkin et al. 2009; Giachino et al. 2005; Herold et al. 2010; 
Mantamadiotis et al. 2002; Riccio et al. 1999), while the role of CREB signalling in the 
proliferation and migration stages of immature neurons is less well defined. In a number of 
studies, the use of phospho-specific CREB antibodies demonstrate that constitutive CREB 
activation is restricted to cells in neurogenic regions (Bender et al. 2001; Dworkin et al. 2007; 
Dworkin et al. 2009; Fujioka et al. 2004; Gampe et al. 2011; Giachino et al. 2005; Herold et al. 
2010; Nakagawa et al. 2002). In zebrafish, phosphorylated CREB is expressed throughout the 
highly proliferative embryonic brain but in the adult expression is restricted to cells in the 
proliferative zones (Dworkin et al. 2007), in patterns identical to those previously reported 
for proliferating cells (Grandel et al. 2006). Taken together, these data suggest a role for 
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CREB in proliferating cells in the post-natal adult vertebrate brain. Furthermore, pCREB is 
also expressed in zones of NSPC migration (Giachino et al. 2005), indicating it may also 
function in maintaining survival of migratory neuroblasts. 
A number of CREB mouse mutants have been critical to the investigation of CREB function 
in vivo. Transgenic mice expressing a dominant-negative mutant CREB shows that CREB 
has a role in cell expansion and survival in the pituitary gland (Struthers et al. 1991) and 
seminiferous tubules of the testis (Scobey et al. 2001). CREB over-expression on the other 
hand results in increased cellular proliferation (Shankar & Sakamoto 2004; Zhu et al. 2004). 
Mice with germline deletion of all CREB isoforms show a decrease in the size of the corpus 
callosum and an increase in lateral ventricle area (Rudolph et al. 1998), consistent with a 
decrease in cellularity and displayed significant defects in brain development which were 
attributed to neurogenic defects (Dworkin et al. 2009). 
Since loss of CREB leads to an upregulation of the related factor CREM as a compensatory 
mechanism for CREB loss, a more sophisticated approach was needed to assess the role of 
CREB signalling loss. Therefore, mice were generated with a germline deletion of CREM 
and lacking CREB specifically in neural cells. These brain-specific compound CREB-CREM 
mutant mice displayed severe neuronal death (Mantamadiotis et al. 2002), stressing the 
importance of CREB signalling in neuronal survival. Further studies on on NSPCs derived 
from CREB-null mice displayed severe defects in survival, cellular expansion and 
neurosphere forming potential (Dworkin et al. 2009). An important question on whether 
CREB is also important for neural expansion comes from studies in mice where a 
transcriptionally constitutive active fusion of the CREB DNA-binding domain with the 
transactivation domain of Herpes Simplex Virus, VP-16-CREB has demonstrated that CREB-
dependent genes contribute to neurogenesis (Zhu et al. 2004). Similarly, a constitutively 
active CREB mutant leads to an overproduction of neural cells in zebrafish embryos while a 
dominant-negative CREB mutant which is able to silence kinase-induced CREB activation, 
has the opposite effect and inhibits neurogenesis (Dworkin et al. 2007). 
The upstream or downstream factors associated with the CREB-dependent mechanisms 
promoting proliferation are not well understood. However, activation of the PI3K/Akt 
pathway by FGF-2 in cultured adult hippocampal NSPCs resulted in increased CREB 
phosphorylation and increased progenitor proliferation and decreased differentiation, as 
did over-expression of wild-type CREB (Peltier et al. 2007). Furthermore, increasing cGMP, 
Akt and GSK3ǃ activity, upstream signals, which phosphorylate CREB, in adult SVZ-
derived neurospheres increased NSPC proliferation, whereas down-regulating these signals 
resulted in decreased proliferation (Peltier et al. 2007). Recent work also shows that CREB-
dependent NSPC proliferation and neurogenesis is mediated via EGF-induced activation of 
both PKA (Iguchi et al. 2011) and ERK (Gampe et al. 2011). All the above mentioned studies 
were performed in animal model organisms or NSPCs derived from these. So far there are 
no reports on the role of the CREB pathway in human NSPCs but recent work shows that 
CREB is activated and functional in neurogenic cells in the adult primate (Japanese 
macacque) brain (Boneva & Yamashima 2011). 
3.2 CREB’s oncogenic properties 
There are numerous reports in cell, animal and human tissue studies showing a positive 
correlation between the level of CREB expression and activation and malignancy. A role for 
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CREB-mediated transcription in cancer was first reported through the identification of a 
chromosomal translocation t(12;22)(q13;q12) in clear cell sarcomas of soft tissue to give a 
fusion protein EWS-ATF1 (Zucman et al. 1993). This chimaeric protein, consisting of the N-
terminal region of EWS (Ewing’s Sarcoma) fused with the C-terminal DNA-binding domain 
of the CREB-related protein ATF1, generates a constitutively active transcription activator 
capable of binding to the promoters of CREB/ATF1 target genes, which in turn promote 
tumour development and growth. More recently, a EWS-CREB1 fusion was discovered in a 
clear cell sarcoma variant (Antonescu et al. 2006) and angiomatoid fibrous histiocytomas 
(Rossi et al. 2007). 
CREB has been implicated in contributing to the progression of several other tumour types 
(Conkright & Montminy 2005; Rosenberg et al. 2002). Analysis of prostate tumors from 
patients demonstrated that pCREB expression was restricted to poorly-differentiated 
prostate cancers and bone metastatic tissue but not to non-tumour benign prostate glands 
(Wu et al. 2007). Increased mRNA levels of CREB are also a feature of breast cancer tissue 
compared to non-tumour mammary tissue and the level of CREB expression correlated with 
disease progression and survival (Chhabra et al. 2007). In non-small-cell lung cancer the 
expression levels of CREB and pCREB were elevated in tumour compared to adjacent 
normal tissues and increased CREB expression correlated with poor patient survival (Seo et 
al. 2008). Human ovarian tumors also exhibit increased CREB expression and ovarian 
tumour cell lines in which CREB expression is silenced display significantly reduced 
proliferation (Linnerth et al. 2008). Some of the best studies implicating CREB in cancer 
development come from evidence showing that CREB has a role in the development of bone 
marrow malignancies. The oncogenic virus human T-cell leukemia virus type 1 (HTLV-1) is 
strongly associated with T-cell leukemia (ATL) [29, 30]. T-cell oncogenic transformation 
mediated by the HTLV-1 Tax oncoprotein requires intact CREB signalling (Smith & Greene 
1991). Moreover, increased CREB and pCREB expression is seen in bone marrow from 
patients with ALL (acute lymphoid leukemia) and AML (acute myeloid leukemia) 
compared to that from healthy patients (Crans-Vargas et al. 2002).  In addition, CREB 
expression and in some cases increased CREB gene copy number correlates with disease 
stage in leukemia patients where CREB overexpression is associated with accelerated 
relapse and event-free survival (Crans-Vargas et al. 2002; Pigazzi et al. 2007; Shankar et al. 
2005). Finally, CREB also appears to regulate malignant melanoma biology by promoting 
tumour cell survival and metastasis (Jean & Bar-Eli 2000; Melnikova et al. 2010). 
How CREB regulates tumour growth is still a question that remains unanswered. An 
obvious approach to unravel the underlying CREB-mediated oncogenic mechanisms is to 
determine the array of “cancer-associated” genes which CREB directly regulates at the level 
of transcription. Several genes known to be directly regulated by CREB are implicated in 
tumourigenesis and uncontrolled proliferation. CREB directly regulates several cell-cycle 
control genes known to be aberrantly expressed in hyper-proliferative disorders, including 
cyclin D1 (Pradeep et al. 2004), cyclin A1 and A2 (Desdouets et al. 1995)(Shankar and 
Sakamoto, 2004), bcl-2 (Wilson et al. 1996),  HEC1 (a cell-cycle regulatory protein which 
localizes to the kinetochore in mitosis and is implicated in cancer progression (H. Y. Cheng 
et al. 2007) and cyclin D2. Increased cyclin D2 transcription following CREB transactivation 
has been implicated in regulating the proliferation of lymphocytes, putatively through 
phosphorylation of CREB by PI3K and PKA (Assanah et al. 2006). In cultured mouse 
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embryonic fibroblasts (MEFs), phosphorylation of CREB by LiCl increases cyclin D2 
expression, whereas inhibition of the CREB-cyclin D2 pathway by the tumour-suppressor 
phosphatase PTEN decreases the abundance of cyclin D2 mRNA and protein (Huang et al. 
2007), indicating that CREB-mediated regulation of cyclin D2 may be a conserved 
partnership regulating proliferation. VEGF was also increased in tandem with increased 
CREB signalling in metastatic prostate cancer derived from human bone (He et al. 2007), 
strongly supporting a direct role for CREB in mediating cellular proliferation and possibly 
metastasis. In human brain tumour derived cell lines there is evidence that CREB can be 
activated by prostaglandin E2 via the PKA pathway to stimulate cell proliferation (Bidwell et 
al. 2010). Thus, data from cell lines, animal models and importantly patient tumour samples, 
indicate that CREB not only serves as a diagnostic marker but also has a role in promoting 
and supporting the development tumors in a variety of cell and tissue types. In the next 
section we discuss the evidence that suggests CREB may also be an important factor in brain 
tumour development and growth. 
4. Converging evidence for the involvement of CREB in brain cancer  
Various studies using brain tumour cell lines suggest that signalling pathways involving 
CREB activation are important for tumour cell growth and differentiation (Bidwell et al. 
2010; Golan et al. 2011; Kim et al. 2010; Morioka et al. 2010). To date there has been no 
evidence linking CREB to brain cancer development or progression in vivo, although a 
number of recent findings linking CREB activity to PTEN and growth factors, together with 
the knowledge of CREB’s role in NSPC biology, lend support to the view that CREB is an 
important factor in brain tumour signalling pathways. Of note, recent data shows that CREB 
is a protein target of PTEN phosphatase activity and that PTEN loss induces CREB-
dependent gene expression and cell growth  (Boneva & Yamashima 2011). PTEN is a 
tumour suppressor gene frequently mutated in many cancers including the most aggressive 
forms of brain cancer, glioblastoma multiforme and related astrocytomas. Indeed PTEN 
expression appears to directly affect glioblastoma growth as well as glioma-initiating cell 
proliferation and self-renewal (R. B. Cheng et al. 2011). Thus, PTEN loss-of-function 
mutations would lead to loss of CREB deactivation, allowing the over activation of CREB-
dependent cell survival and growth signals in brain cancer stem cells or brain tumour 
initiating cells (BTICs). Other important signalling pathways in patient brain tumour cells 
are the epidermal growth factor receptor (EGFR) and the platelet-derived growth factor 
receptor (PDGFR) pathways (Brennan et al. 2009). EGFR activation is important for glioma 
stem/progenitor cell growth and resistance to anti-cancer treatments (Murat et al. 2008). 
EGF is able to induce CREB in NSPCs in vivo (Gampe et al. 2011); most likely acting through 
EGFR induced CREB activation via the Ras-MAPK dependent kinase, RSK-2 (Xing et al. 
1996). Furthermore, there is evidence that CREB is activated in human glioma cells lines and 
that inhibition of CREB leads to reduced survival of glioma cells (Malla et al. 2010). This 
study also shows that PDGFR-dependent PI3K/Akt signals which converge upon CREB are 
important for tumour invasiveness, a process which BTICs use to migrate and generate 
metastatic tumors. 
Data from the Human Protein Atlas (www.proteinatlas.org) shows that CREB is highly 
expressed in all glioma patient samples tested (24 cases) and consistent with the mouse data, 
human brain also shows robust CREB expression in neurogenic zones (Figure 3). Data from 
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our own laboratory shows that human glioma tumour tissue (40 cases) exhibits robust 
pCREB expression compared to only weak staining in non-tumour tissue controls 
(unpublished data). This implies that the CREB pathway is overactive in human glioma 
cells, thereby driving the survival and growth of these cells. More interest is the potential 
role that CREB may be playing in the glioma stem cells, which are the cellular source of the 
tumour and which may also be responsible for the relapse of tumour growth following 
therapy. Data from primary mouse NSPCs shows that CREB is required for the expression 
of various growth and survival factors including BDNF, NGF, PACAP and Bcl-2 (Dworkin 
et al. 2009). It is likely that the expression of growth and survival factors will be dependent 
upon CREB-dependent transcription. 
 
Fig. 3. CREB expression is human brain. 
A) CREB expression is enriched in the human brain SVZ, as seen by the intense nuclear 
staining of cells lining the ventricular space (indicated by arrow heads). B) Intense CREB 
expression is clearly evident in human high grade glioma. The non-tumour cells show weak 
staining (behind the arrow heads). According to the Human Protein Atlas data, 100% (24 
cases) of brain tumour samples tested exhibited strong CREB expression (Uhlen et al., Nat 
Biotechnol. 2010 28(12):1248-50 and http://www.proteinatlas.org). The images were from the 
Human Protein Atlas database. 
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5. Conclusion 
In conclusion, there is significant emerging experimental data implicating the CREB signalling 
pathway in the development and maintenance of brain tumors. Investigation of the CREB 
signalling pathway and transcriptome in glioma cell lines, BTICs and new animal models will 
shed light on the importance of this pathway in glioma biology. This knowledge will provide 
an opportunity to investigate novel drug targeting approaches in glioma treatment, targeting 
CREB itself or an upstream or downstream component of the CREB-pathway. Opinions on 
whether widely expressed factors which are critical to cell function are good targets vary 
widely and have evolved over the last decades. CREB may well prove to be a good anti-
tumour target in the brain, as tumors seem to express high levels of the activated 
phosphorylated form. This is in contrast with the physiologically normal adult brain which 
only transiently exhibits pCREB expression only in discreet nuclei responsible for a specific 
neuronal response (eg. the suprachiasmatic nucleus in response to visual light stimulation). 
This observation together with the ever advancing drug delivery technologies may allow 
targeting of CREB in brain tumors with minimal toxicity to neurons outside the tumour. 
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